Walleye Capital
TENX icon

Walleye Capital’s Tenax Therapeutics TENX Stock Holding History

Walleye Capital’s Portfolio TENX Stock Details TENX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.53M Buy
+105,237
New +$1.34M 0.01% 1751

Other funds holding TENX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
DT
Diversified Trust Memphis, Tennessee $6.24B AUM 28.78% 1-Year Est. Return
KPF
K2 Principal Fund Toronto, Ontario, Canada $1.36B AUM 25.57% 1-Year Est. Return

Walleye Capital's TENX Position: Q2 2026 in Review

Walleye Capital opened a new position in Tenax Therapeutics (TENX) in Q2 2026: 105,237 shares worth $1.53M. The stake represents 0.01% of the portfolio and ranks #1751 among its holdings.

23 funds tracked by Wall St. Rank hold TENX as of Q2 2026.

  • Walleye Capital held 105,237 shares of Tenax Therapeutics worth $1.53M as of Q2 2026.
  • Tenax Therapeutics was a new Walleye Capital position in Q2 2026.
  • Tenax Therapeutics made up 0.01% of Walleye Capital's portfolio in Q2 2026, its #1751 holding.
  • 23 funds tracked by Wall St. Rank held Tenax Therapeutics as of Q2 2026.

Based on Walleye Capital's 13F filing for Q2 2026, filed 3 Aug 2026.